

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.62375660 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.17348059 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.09272412 |
| 4 | locomotory exploration behavior (GO:0035641) | 6.06578792 |
| 5 | glutamate secretion (GO:0014047) | 5.94456921 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.81876780 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.81261570 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.78863717 |
| 9 | vocalization behavior (GO:0071625) | 5.65475591 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.50129590 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.39511225 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.24093077 |
| 13 | protein localization to synapse (GO:0035418) | 5.20823501 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.07555138 |
| 15 | regulation of neuronal synaptic plasticity (GO:0048168) | 5.04955323 |
| 16 | exploration behavior (GO:0035640) | 4.89911062 |
| 17 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.89648663 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.79644239 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.76284920 |
| 20 | central nervous system myelination (GO:0022010) | 4.74792304 |
| 21 | axon ensheathment in central nervous system (GO:0032291) | 4.74792304 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.72201513 |
| 23 | amino acid import (GO:0043090) | 4.68564724 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 4.54215347 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 4.52948826 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.42640534 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 4.38659645 |
| 28 | cerebellar granule cell differentiation (GO:0021707) | 4.38466674 |
| 29 | neurotransmitter secretion (GO:0007269) | 4.33477774 |
| 30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.19126277 |
| 31 | dendritic spine morphogenesis (GO:0060997) | 4.15150726 |
| 32 | positive regulation of membrane potential (GO:0045838) | 4.12835770 |
| 33 | regulation of synaptic plasticity (GO:0048167) | 4.10433985 |
| 34 | proline transport (GO:0015824) | 4.09953172 |
| 35 | long-term memory (GO:0007616) | 4.09857685 |
| 36 | neuron-neuron synaptic transmission (GO:0007270) | 4.08450567 |
| 37 | potassium ion homeostasis (GO:0055075) | 4.07976213 |
| 38 | neuronal ion channel clustering (GO:0045161) | 4.04221424 |
| 39 | regulation of synapse structural plasticity (GO:0051823) | 4.04007174 |
| 40 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.01589648 |
| 41 | regulation of postsynaptic membrane potential (GO:0060078) | 3.93276347 |
| 42 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.88979444 |
| 43 | positive regulation of synapse maturation (GO:0090129) | 3.87880847 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.86041288 |
| 45 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.85585835 |
| 46 | potassium ion import (GO:0010107) | 3.83726854 |
| 47 | long-term synaptic potentiation (GO:0060291) | 3.81505033 |
| 48 | cellular potassium ion homeostasis (GO:0030007) | 3.71213360 |
| 49 | layer formation in cerebral cortex (GO:0021819) | 3.70673937 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.63932536 |
| 51 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.63092653 |
| 52 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.61695232 |
| 53 | neuron recognition (GO:0008038) | 3.58836863 |
| 54 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.57339259 |
| 55 | dendritic spine organization (GO:0097061) | 3.56628014 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.56117489 |
| 57 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.54888343 |
| 58 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.50681813 |
| 59 | neurotransmitter transport (GO:0006836) | 3.50462396 |
| 60 | regulation of vesicle fusion (GO:0031338) | 3.46634536 |
| 61 | activation of protein kinase A activity (GO:0034199) | 3.45828059 |
| 62 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.43012478 |
| 63 | acidic amino acid transport (GO:0015800) | 3.41549217 |
| 64 | postsynaptic membrane organization (GO:0001941) | 3.40214734 |
| 65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.38592013 |
| 66 | gamma-aminobutyric acid transport (GO:0015812) | 3.36450979 |
| 67 | innervation (GO:0060384) | 3.36406417 |
| 68 | behavioral defense response (GO:0002209) | 3.36284963 |
| 69 | behavioral fear response (GO:0001662) | 3.36284963 |
| 70 | neuromuscular process controlling balance (GO:0050885) | 3.35916935 |
| 71 | regulation of dendritic spine development (GO:0060998) | 3.32097730 |
| 72 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.31572259 |
| 73 | sodium ion export (GO:0071436) | 3.31400022 |
| 74 | vesicle docking involved in exocytosis (GO:0006904) | 3.30770416 |
| 75 | cellular sodium ion homeostasis (GO:0006883) | 3.29554992 |
| 76 | presynaptic membrane assembly (GO:0097105) | 3.29019503 |
| 77 | neurotransmitter uptake (GO:0001504) | 3.29018979 |
| 78 | axonal fasciculation (GO:0007413) | 3.27863132 |
| 79 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.26764522 |
| 80 | membrane depolarization (GO:0051899) | 3.26676858 |
| 81 | positive regulation of dendritic spine development (GO:0060999) | 3.26199319 |
| 82 | regulation of synaptic transmission (GO:0050804) | 3.23978779 |
| 83 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.23315626 |
| 84 | regulation of neurotransmitter levels (GO:0001505) | 3.22925899 |
| 85 | regulation of neurotransmitter transport (GO:0051588) | 3.20408424 |
| 86 | positive regulation of neurotransmitter transport (GO:0051590) | 3.20106235 |
| 87 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.19717938 |
| 88 | neuromuscular synaptic transmission (GO:0007274) | 3.19375885 |
| 89 | transmission of nerve impulse (GO:0019226) | 3.19285681 |
| 90 | cell communication by electrical coupling (GO:0010644) | 3.19217425 |
| 91 | positive regulation of synaptic transmission (GO:0050806) | 3.17345427 |
| 92 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.16601790 |
| 93 | chemosensory behavior (GO:0007635) | 3.14447899 |
| 94 | response to histamine (GO:0034776) | 3.13341561 |
| 95 | vesicle transport along microtubule (GO:0047496) | 3.13229529 |
| 96 | positive regulation of fibroblast migration (GO:0010763) | 3.13066042 |
| 97 | response to gravity (GO:0009629) | 3.12939797 |
| 98 | fear response (GO:0042596) | 3.12854795 |
| 99 | vesicle docking (GO:0048278) | 3.11998290 |
| 100 | learning (GO:0007612) | 3.11846851 |
| 101 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.09295610 |
| 102 | detection of calcium ion (GO:0005513) | 3.09292524 |
| 103 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.09124073 |
| 104 | regulation of glutamate secretion (GO:0014048) | 3.07871838 |
| 105 | L-amino acid import (GO:0043092) | 3.07061575 |
| 106 | synaptic transmission (GO:0007268) | 3.05994750 |
| 107 | negative regulation of amino acid transport (GO:0051956) | 3.05919338 |
| 108 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.05400033 |
| 109 | membrane depolarization during action potential (GO:0086010) | 3.05384936 |
| 110 | neuromuscular process controlling posture (GO:0050884) | 3.05246567 |
| 111 | L-glutamate transport (GO:0015813) | 3.05060645 |
| 112 | phosphorelay signal transduction system (GO:0000160) | 3.01855691 |
| 113 | presynaptic membrane organization (GO:0097090) | 3.00921087 |
| 114 | dendrite morphogenesis (GO:0048813) | 3.00294045 |
| 115 | synaptic vesicle transport (GO:0048489) | 2.98371705 |
| 116 | establishment of synaptic vesicle localization (GO:0097480) | 2.98371705 |
| 117 | regulation of synapse maturation (GO:0090128) | 2.96966354 |
| 118 | social behavior (GO:0035176) | 2.96184494 |
| 119 | intraspecies interaction between organisms (GO:0051703) | 2.96184494 |
| 120 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.94666081 |
| 121 | serotonin metabolic process (GO:0042428) | 2.93977171 |
| 122 | regulation of ARF protein signal transduction (GO:0032012) | 2.93548296 |
| 123 | long term synaptic depression (GO:0060292) | 2.93026297 |
| 124 | neuromuscular process (GO:0050905) | 2.91766219 |
| 125 | regulation of exocytosis (GO:0017157) | 2.91451685 |
| 126 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.90621046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.50456687 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.63792972 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.24261160 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.17020063 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.13401984 |
| 6 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.82780276 |
| 7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.82780276 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.79189861 |
| 9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.77656661 |
| 10 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.74356013 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.73884686 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.65670408 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.60006425 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.58609927 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53765756 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51514192 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49975539 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39346448 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.28871316 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.28031999 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.27713992 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.27618237 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.24916267 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.01439803 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95764696 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.92867330 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83311159 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77445799 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75024415 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72801278 |
| 31 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66410821 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66281218 |
| 33 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62868722 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52861928 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52694314 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46659748 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.43111200 |
| 38 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39067935 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38837484 |
| 40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37307640 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36006032 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35065586 |
| 43 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34262058 |
| 44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32083924 |
| 45 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.30890343 |
| 46 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30318076 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30124695 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29717766 |
| 49 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.29425642 |
| 50 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28868017 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27894977 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26522053 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22628172 |
| 54 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.22095429 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19500921 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16935944 |
| 57 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16743265 |
| 58 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16293570 |
| 59 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.15957917 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15882380 |
| 61 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.15790978 |
| 62 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13655059 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13325562 |
| 64 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.12967779 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12159855 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11972288 |
| 67 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11462867 |
| 68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07474786 |
| 69 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06794436 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06627073 |
| 71 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06509929 |
| 72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06333110 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05990305 |
| 74 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04514532 |
| 75 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04397284 |
| 76 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03862218 |
| 77 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03643393 |
| 78 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.03336581 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03221525 |
| 80 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02702405 |
| 81 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02125697 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01294297 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00999494 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99591758 |
| 85 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.99342601 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99329774 |
| 87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98168575 |
| 88 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97748786 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97717692 |
| 90 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97408451 |
| 91 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.95983590 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95366505 |
| 93 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.94966973 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94756186 |
| 95 | JUN_21703547_ChIP-Seq_K562_Human | 0.94678477 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94382668 |
| 97 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94346823 |
| 98 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93113021 |
| 99 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93011374 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92777496 |
| 101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92263357 |
| 102 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92056878 |
| 103 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92021199 |
| 104 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92010448 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91715944 |
| 106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91600347 |
| 107 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91191822 |
| 108 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90488297 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89895218 |
| 110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89158728 |
| 111 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87356878 |
| 112 | VDR_22108803_ChIP-Seq_LS180_Human | 0.86810468 |
| 113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86649370 |
| 114 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.85400547 |
| 115 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.85061918 |
| 116 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.84320898 |
| 117 | KDM2B_26808549_Chip-Seq_REH_Human | 0.82241354 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82206476 |
| 119 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79302518 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79006055 |
| 121 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.77998220 |
| 122 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.77624836 |
| 123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77509538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.81983989 |
| 2 | MP0003880_abnormal_central_pattern | 5.35562580 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.44328757 |
| 4 | MP0004270_analgesia | 3.81547717 |
| 5 | MP0009745_abnormal_behavioral_response | 3.59603531 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.58281513 |
| 7 | MP0002064_seizures | 3.31511665 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.22964471 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.89543147 |
| 10 | MP0009046_muscle_twitch | 2.83027037 |
| 11 | MP0002736_abnormal_nociception_after | 2.64687706 |
| 12 | MP0002272_abnormal_nervous_system | 2.61349961 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.56458159 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.54938392 |
| 15 | MP0001486_abnormal_startle_reflex | 2.43494178 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.36616390 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.32337150 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.25949093 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.14032266 |
| 20 | MP0002822_catalepsy | 2.08514081 |
| 21 | MP0004858_abnormal_nervous_system | 1.97739769 |
| 22 | MP0003329_amyloid_beta_deposits | 1.97253306 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.94543991 |
| 24 | MP0001970_abnormal_pain_threshold | 1.92996149 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.86516836 |
| 26 | MP0004811_abnormal_neuron_physiology | 1.80300941 |
| 27 | MP0008569_lethality_at_weaning | 1.77871033 |
| 28 | MP0003879_abnormal_hair_cell | 1.77513383 |
| 29 | MP0002184_abnormal_innervation | 1.69126346 |
| 30 | MP0000778_abnormal_nervous_system | 1.68717929 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.63968240 |
| 32 | MP0003787_abnormal_imprinting | 1.59738230 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.56316913 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.50566201 |
| 35 | MP0004924_abnormal_behavior | 1.50566201 |
| 36 | MP0000955_abnormal_spinal_cord | 1.47414830 |
| 37 | MP0006276_abnormal_autonomic_nervous | 1.47290127 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.42853235 |
| 39 | MP0002066_abnormal_motor_capabilities/c | 1.38886788 |
| 40 | MP0003633_abnormal_nervous_system | 1.38037818 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.36851531 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.30453500 |
| 43 | MP0004885_abnormal_endolymph | 1.30428197 |
| 44 | MP0001984_abnormal_olfaction | 1.29065220 |
| 45 | MP0001905_abnormal_dopamine_level | 1.26248049 |
| 46 | MP0003122_maternal_imprinting | 1.26093964 |
| 47 | MP0003075_altered_response_to | 1.21659357 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.20289414 |
| 49 | MP0003631_nervous_system_phenotype | 1.15453276 |
| 50 | MP0004142_abnormal_muscle_tone | 1.06393898 |
| 51 | MP0000751_myopathy | 1.04950556 |
| 52 | MP0002152_abnormal_brain_morphology | 1.02355562 |
| 53 | MP0008874_decreased_physiological_sensi | 0.96625846 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 0.93516824 |
| 55 | MP0002069_abnormal_eating/drinking_beha | 0.91257344 |
| 56 | MP0001177_atelectasis | 0.90438434 |
| 57 | MP0000604_amyloidosis | 0.90109913 |
| 58 | MP0004510_myositis | 0.89805347 |
| 59 | MP0008872_abnormal_physiological_respon | 0.89709146 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 0.88709596 |
| 61 | MP0001348_abnormal_lacrimal_gland | 0.88443326 |
| 62 | MP0001986_abnormal_taste_sensitivity | 0.86147735 |
| 63 | MP0002876_abnormal_thyroid_physiology | 0.85811368 |
| 64 | MP0001299_abnormal_eye_distance/ | 0.85185222 |
| 65 | MP0010386_abnormal_urinary_bladder | 0.85064794 |
| 66 | MP0004484_altered_response_of | 0.84464399 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 0.84344391 |
| 68 | MP0002229_neurodegeneration | 0.83786457 |
| 69 | MP0001529_abnormal_vocalization | 0.83301515 |
| 70 | MP0004147_increased_porphyrin_level | 0.81992444 |
| 71 | MP0005535_abnormal_body_temperature | 0.81882064 |
| 72 | MP0001346_abnormal_lacrimal_gland | 0.80085050 |
| 73 | MP0001963_abnormal_hearing_physiology | 0.79941895 |
| 74 | MP0001958_emphysema | 0.78979273 |
| 75 | MP0000013_abnormal_adipose_tissue | 0.78009946 |
| 76 | MP0005623_abnormal_meninges_morphology | 0.76414935 |
| 77 | MP0004085_abnormal_heartbeat | 0.74760756 |
| 78 | MP0001188_hyperpigmentation | 0.74577149 |
| 79 | MP0003283_abnormal_digestive_organ | 0.72947972 |
| 80 | MP0003632_abnormal_nervous_system | 0.72316747 |
| 81 | MP0003634_abnormal_glial_cell | 0.71959049 |
| 82 | MP0008961_abnormal_basal_metabolism | 0.70847967 |
| 83 | MP0003690_abnormal_glial_cell | 0.70188764 |
| 84 | MP0001664_abnormal_digestion | 0.69665043 |
| 85 | MP0003045_fibrosis | 0.68333045 |
| 86 | MP0000920_abnormal_myelination | 0.65661666 |
| 87 | MP0004742_abnormal_vestibular_system | 0.65568423 |
| 88 | MP0000569_abnormal_digit_pigmentation | 0.65468627 |
| 89 | MP0003123_paternal_imprinting | 0.65407937 |
| 90 | MP0004215_abnormal_myocardial_fiber | 0.64485476 |
| 91 | MP0004130_abnormal_muscle_cell | 0.64152101 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 0.63780579 |
| 93 | MP0005551_abnormal_eye_electrophysiolog | 0.63597972 |
| 94 | MP0005171_absent_coat_pigmentation | 0.62521639 |
| 95 | MP0005499_abnormal_olfactory_system | 0.62278491 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.62278491 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.61948181 |
| 98 | MP0002752_abnormal_somatic_nervous | 0.61930605 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.59582219 |
| 100 | MP0004233_abnormal_muscle_weight | 0.58955061 |
| 101 | MP0008877_abnormal_DNA_methylation | 0.58036663 |
| 102 | MP0000631_abnormal_neuroendocrine_gland | 0.55679116 |
| 103 | MP0002090_abnormal_vision | 0.54687477 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.52305804 |
| 105 | MP0005388_respiratory_system_phenotype | 0.51259885 |
| 106 | MP0002133_abnormal_respiratory_system | 0.51259885 |
| 107 | MP0003137_abnormal_impulse_conducting | 0.50542584 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.50347734 |
| 109 | MP0003172_abnormal_lysosome_physiology | 0.49560231 |
| 110 | MP0005166_decreased_susceptibility_to | 0.49499483 |
| 111 | MP0001943_abnormal_respiration | 0.49152734 |
| 112 | MP0000749_muscle_degeneration | 0.48553096 |
| 113 | MP0010768_mortality/aging | 0.47790958 |
| 114 | MP0003956_abnormal_body_size | 0.47509470 |
| 115 | MP0003279_aneurysm | 0.47498230 |
| 116 | MP0003861_abnormal_nervous_system | 0.46812702 |
| 117 | MP0002082_postnatal_lethality | 0.46720894 |
| 118 | MP0010770_preweaning_lethality | 0.46720894 |
| 119 | MP0002089_abnormal_postnatal_growth/wei | 0.46505101 |
| 120 | MP0010769_abnormal_survival | 0.46428553 |
| 121 | MP0002295_abnormal_pulmonary_circulatio | 0.46107959 |
| 122 | MP0000747_muscle_weakness | 0.44422218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.58931704 |
| 2 | Myokymia (HP:0002411) | 7.75138561 |
| 3 | Focal seizures (HP:0007359) | 6.20591042 |
| 4 | Visual hallucinations (HP:0002367) | 5.63742377 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.36282667 |
| 6 | Atonic seizures (HP:0010819) | 5.15289809 |
| 7 | Febrile seizures (HP:0002373) | 4.66606974 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.57248370 |
| 9 | Absence seizures (HP:0002121) | 4.39938235 |
| 10 | Dialeptic seizures (HP:0011146) | 4.15723859 |
| 11 | Action tremor (HP:0002345) | 4.14166222 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.10418954 |
| 13 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.72408153 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.57498662 |
| 15 | Amblyopia (HP:0000646) | 3.54306944 |
| 16 | Hyperventilation (HP:0002883) | 3.51855536 |
| 17 | Abnormality of the lower motor neuron (HP:0002366) | 3.45113190 |
| 18 | Broad-based gait (HP:0002136) | 3.43529861 |
| 19 | Depression (HP:0000716) | 3.39191964 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 3.38305481 |
| 21 | Poor eye contact (HP:0000817) | 3.35137446 |
| 22 | Dysmetria (HP:0001310) | 3.29544090 |
| 23 | Dysdiadochokinesis (HP:0002075) | 3.18741639 |
| 24 | Cerebral hypomyelination (HP:0006808) | 3.18077483 |
| 25 | Akinesia (HP:0002304) | 3.15177010 |
| 26 | Tetraplegia (HP:0002445) | 3.10753653 |
| 27 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.07694596 |
| 28 | Postural instability (HP:0002172) | 3.07444704 |
| 29 | Anxiety (HP:0000739) | 3.06002385 |
| 30 | Ankle clonus (HP:0011448) | 3.04022511 |
| 31 | Abnormal eating behavior (HP:0100738) | 3.02125002 |
| 32 | Papilledema (HP:0001085) | 2.95920412 |
| 33 | Impaired social interactions (HP:0000735) | 2.94081130 |
| 34 | Abnormal social behavior (HP:0012433) | 2.94081130 |
| 35 | Truncal ataxia (HP:0002078) | 2.93898869 |
| 36 | Limb dystonia (HP:0002451) | 2.92116110 |
| 37 | Neuronal loss in central nervous system (HP:0002529) | 2.82780285 |
| 38 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.78040186 |
| 39 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.78040186 |
| 40 | Clonus (HP:0002169) | 2.69748117 |
| 41 | Mutism (HP:0002300) | 2.69156773 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.69086208 |
| 43 | Impaired smooth pursuit (HP:0007772) | 2.67791903 |
| 44 | Genetic anticipation (HP:0003743) | 2.67354734 |
| 45 | Urinary urgency (HP:0000012) | 2.66598069 |
| 46 | Termporal pattern (HP:0011008) | 2.64075706 |
| 47 | Insidious onset (HP:0003587) | 2.64075706 |
| 48 | Bradykinesia (HP:0002067) | 2.63496141 |
| 49 | Excessive salivation (HP:0003781) | 2.61877286 |
| 50 | Drooling (HP:0002307) | 2.61877286 |
| 51 | Epileptiform EEG discharges (HP:0011182) | 2.56591976 |
| 52 | Stereotypic behavior (HP:0000733) | 2.54112226 |
| 53 | Impaired vibratory sensation (HP:0002495) | 2.53605984 |
| 54 | Focal dystonia (HP:0004373) | 2.51028818 |
| 55 | Torticollis (HP:0000473) | 2.49585509 |
| 56 | Ventricular fibrillation (HP:0001663) | 2.43594283 |
| 57 | Peripheral hypomyelination (HP:0007182) | 2.43561864 |
| 58 | Annular pancreas (HP:0001734) | 2.42481178 |
| 59 | Diplopia (HP:0000651) | 2.40803707 |
| 60 | Abnormality of binocular vision (HP:0011514) | 2.40803707 |
| 61 | Apathy (HP:0000741) | 2.38174024 |
| 62 | Spastic gait (HP:0002064) | 2.35661596 |
| 63 | Neurofibrillary tangles (HP:0002185) | 2.34846442 |
| 64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.34459295 |
| 65 | Hemiparesis (HP:0001269) | 2.34108488 |
| 66 | Scanning speech (HP:0002168) | 2.33593873 |
| 67 | Progressive inability to walk (HP:0002505) | 2.32523356 |
| 68 | Delusions (HP:0000746) | 2.32062184 |
| 69 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.31034129 |
| 70 | Megalencephaly (HP:0001355) | 2.28429328 |
| 71 | Intention tremor (HP:0002080) | 2.27692956 |
| 72 | Spastic tetraparesis (HP:0001285) | 2.25821513 |
| 73 | Absent speech (HP:0001344) | 2.25573485 |
| 74 | Generalized myoclonic seizures (HP:0002123) | 2.25365213 |
| 75 | Hemiplegia (HP:0002301) | 2.24266666 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.23217189 |
| 77 | Hypsarrhythmia (HP:0002521) | 2.20283000 |
| 78 | Dysmetric saccades (HP:0000641) | 2.19717644 |
| 79 | Status epilepticus (HP:0002133) | 2.15819104 |
| 80 | Incomplete penetrance (HP:0003829) | 2.12063332 |
| 81 | Diminished motivation (HP:0000745) | 2.11373089 |
| 82 | Lower limb muscle weakness (HP:0007340) | 2.11062456 |
| 83 | Inability to walk (HP:0002540) | 2.10005761 |
| 84 | Pointed chin (HP:0000307) | 2.09214120 |
| 85 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.08988109 |
| 86 | Obstructive sleep apnea (HP:0002870) | 2.06054874 |
| 87 | Craniofacial dystonia (HP:0012179) | 2.05648777 |
| 88 | Bundle branch block (HP:0011710) | 2.04324382 |
| 89 | Choreoathetosis (HP:0001266) | 2.00979611 |
| 90 | Gait ataxia (HP:0002066) | 1.98967852 |
| 91 | Rapidly progressive (HP:0003678) | 1.94701332 |
| 92 | Lower limb asymmetry (HP:0100559) | 1.94562658 |
| 93 | Pheochromocytoma (HP:0002666) | 1.94105203 |
| 94 | Mild short stature (HP:0003502) | 1.92849960 |
| 95 | Distal upper limb amyotrophy (HP:0007149) | 1.92733456 |
| 96 | Upper limb amyotrophy (HP:0009129) | 1.92733456 |
| 97 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.90936203 |
| 98 | Agitation (HP:0000713) | 1.89824573 |
| 99 | Insomnia (HP:0100785) | 1.89460655 |
| 100 | Hand muscle atrophy (HP:0009130) | 1.89232501 |
| 101 | CNS hypomyelination (HP:0003429) | 1.89190167 |
| 102 | Abnormality of the corticospinal tract (HP:0002492) | 1.87472901 |
| 103 | Lower limb amyotrophy (HP:0007210) | 1.87299825 |
| 104 | Blue irides (HP:0000635) | 1.83681532 |
| 105 | Polyphagia (HP:0002591) | 1.82241271 |
| 106 | Hypoventilation (HP:0002791) | 1.82178489 |
| 107 | Rigidity (HP:0002063) | 1.81138900 |
| 108 | Memory impairment (HP:0002354) | 1.80984770 |
| 109 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.80796039 |
| 110 | Aplasia of the phalanges of the hand (HP:0009802) | 1.80796039 |
| 111 | Aplasia involving bones of the extremities (HP:0009825) | 1.80796039 |
| 112 | Abnormality of salivation (HP:0100755) | 1.80779339 |
| 113 | Psychosis (HP:0000709) | 1.79868295 |
| 114 | Spinal canal stenosis (HP:0003416) | 1.79044929 |
| 115 | Ankyloglossia (HP:0010296) | 1.76957943 |
| 116 | Slow progression (HP:0003677) | 1.74511023 |
| 117 | Anosmia (HP:0000458) | 1.73155385 |
| 118 | Heart block (HP:0012722) | 1.72457918 |
| 119 | Thickened helices (HP:0000391) | 1.65788463 |
| 120 | Increased circulating renin level (HP:0000848) | 1.64564521 |
| 121 | Sleep apnea (HP:0010535) | 1.63930493 |
| 122 | Neuroendocrine neoplasm (HP:0100634) | 1.63366963 |
| 123 | Abnormality of saccadic eye movements (HP:0000570) | 1.62738141 |
| 124 | Abnormal EKG (HP:0003115) | 1.61664217 |
| 125 | Protruding tongue (HP:0010808) | 1.61062865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.19673233 |
| 2 | EPHA4 | 4.68011991 |
| 3 | MAP3K9 | 3.99610864 |
| 4 | MAP3K4 | 2.83854777 |
| 5 | DAPK2 | 2.71559787 |
| 6 | KSR2 | 2.70893549 |
| 7 | MINK1 | 2.69078075 |
| 8 | MAP2K7 | 2.42417976 |
| 9 | PAK6 | 2.39778263 |
| 10 | MAP3K12 | 2.34831924 |
| 11 | PRKD3 | 2.26447577 |
| 12 | MARK1 | 1.95566436 |
| 13 | ARAF | 1.94771489 |
| 14 | KSR1 | 1.94029162 |
| 15 | CASK | 1.92251321 |
| 16 | PRPF4B | 1.90426266 |
| 17 | RIPK4 | 1.89323637 |
| 18 | MAP2K4 | 1.86149816 |
| 19 | DAPK1 | 1.82276447 |
| 20 | PLK2 | 1.78021443 |
| 21 | MAP3K13 | 1.73346369 |
| 22 | CAMKK1 | 1.72921653 |
| 23 | CDK19 | 1.58937284 |
| 24 | NTRK1 | 1.54821718 |
| 25 | CDK5 | 1.50277663 |
| 26 | NTRK2 | 1.49992693 |
| 27 | GRK5 | 1.48606035 |
| 28 | MAP3K2 | 1.45461101 |
| 29 | PTK2B | 1.43496611 |
| 30 | STK38 | 1.39275942 |
| 31 | FES | 1.32478348 |
| 32 | TNIK | 1.31482521 |
| 33 | RAF1 | 1.22703458 |
| 34 | PRKCG | 1.22338877 |
| 35 | LATS2 | 1.13474333 |
| 36 | MAPK13 | 1.11730703 |
| 37 | LIMK1 | 1.11347352 |
| 38 | RIPK1 | 1.09618929 |
| 39 | NME1 | 1.05758547 |
| 40 | CAMK1 | 1.04790380 |
| 41 | CAMK2A | 1.04776470 |
| 42 | SIK2 | 1.04231528 |
| 43 | PNCK | 1.03947689 |
| 44 | TYRO3 | 0.90378197 |
| 45 | CDK18 | 0.89727123 |
| 46 | CDK15 | 0.86472931 |
| 47 | BMPR2 | 0.84933060 |
| 48 | CDK14 | 0.84350799 |
| 49 | CAMK2B | 0.83846722 |
| 50 | UHMK1 | 0.83661892 |
| 51 | MAPK12 | 0.83043311 |
| 52 | TAOK1 | 0.82238460 |
| 53 | PAK3 | 0.80318913 |
| 54 | LMTK2 | 0.78998743 |
| 55 | MAP3K1 | 0.78763616 |
| 56 | OXSR1 | 0.78658792 |
| 57 | RET | 0.76569992 |
| 58 | SGK223 | 0.74532591 |
| 59 | SGK494 | 0.74532591 |
| 60 | CDK11A | 0.74457108 |
| 61 | PRKCH | 0.74113355 |
| 62 | PDK1 | 0.73171267 |
| 63 | STK11 | 0.71733220 |
| 64 | FER | 0.71000498 |
| 65 | PKN1 | 0.70685561 |
| 66 | MAP3K11 | 0.66849507 |
| 67 | PDPK1 | 0.65479160 |
| 68 | CAMKK2 | 0.63943806 |
| 69 | FGR | 0.63757399 |
| 70 | SGK1 | 0.62612169 |
| 71 | WNK1 | 0.62245445 |
| 72 | SGK2 | 0.61865030 |
| 73 | MOS | 0.61556967 |
| 74 | PINK1 | 0.59957580 |
| 75 | MAP3K7 | 0.57968475 |
| 76 | PHKG2 | 0.57409159 |
| 77 | PHKG1 | 0.57409159 |
| 78 | BRAF | 0.56894217 |
| 79 | CCNB1 | 0.56538204 |
| 80 | MAP2K1 | 0.56498224 |
| 81 | DYRK1A | 0.55814970 |
| 82 | TESK1 | 0.52939979 |
| 83 | DAPK3 | 0.51537401 |
| 84 | SGK3 | 0.51140814 |
| 85 | SIK3 | 0.50844977 |
| 86 | MARK2 | 0.50538742 |
| 87 | FGFR2 | 0.49888880 |
| 88 | ALK | 0.48447944 |
| 89 | ROCK1 | 0.47742329 |
| 90 | TNK2 | 0.46996592 |
| 91 | CAMK2D | 0.44194517 |
| 92 | PRKCE | 0.43993956 |
| 93 | RPS6KA3 | 0.41485108 |
| 94 | CAMK4 | 0.41151198 |
| 95 | DDR2 | 0.40681680 |
| 96 | CAMK2G | 0.40442199 |
| 97 | PDGFRA | 0.40416925 |
| 98 | CSNK1G2 | 0.38328161 |
| 99 | PRKG2 | 0.37263432 |
| 100 | DMPK | 0.36542632 |
| 101 | PRKCZ | 0.36519000 |
| 102 | AKT3 | 0.36133635 |
| 103 | FYN | 0.35260593 |
| 104 | BRSK1 | 0.34736424 |
| 105 | MAPK10 | 0.34058023 |
| 106 | PTK2 | 0.33997250 |
| 107 | MAP3K6 | 0.33370256 |
| 108 | CDC42BPA | 0.32838525 |
| 109 | NEK6 | 0.32456088 |
| 110 | PRKG1 | 0.32106291 |
| 111 | PAK2 | 0.32101767 |
| 112 | NEK1 | 0.31375654 |
| 113 | JAK1 | 0.30367445 |
| 114 | ROCK2 | 0.29065562 |
| 115 | PRKCB | 0.28835858 |
| 116 | PRKCA | 0.27184428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.69171081 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.45285647 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.95282525 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.83534033 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.78350313 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.67153771 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.61596836 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.60318763 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.49848971 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.35849033 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.25061173 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.24309741 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08027429 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.07110380 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.99492583 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.94318609 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85465460 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.75438027 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.71110341 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.68760939 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.68226752 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.67787144 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.66913799 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64448620 |
| 25 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.61623540 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54947317 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48875388 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45371670 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.36447634 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35335672 |
| 31 | Glioma_Homo sapiens_hsa05214 | 1.33343569 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.30099772 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.28294359 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27966260 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19296760 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17302104 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12732746 |
| 38 | Melanogenesis_Homo sapiens_hsa04916 | 1.10746485 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.09933755 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06698513 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06670032 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05861978 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05410747 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.03201697 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99264626 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96916070 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96565927 |
| 48 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.94433783 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.89956609 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89877419 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87169424 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85669168 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85139938 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.82895071 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82883520 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80789743 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78686975 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78369698 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77585504 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76374809 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70895847 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67146071 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66187800 |
| 64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65962133 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63622261 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61395476 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.60449249 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57641326 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53648113 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53040125 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.52027208 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50706325 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50054457 |
| 74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49552452 |
| 75 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49290881 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49146969 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48985999 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.48563951 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46851744 |
| 80 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42367993 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41766905 |
| 82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41617798 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40841857 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.40657515 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.39171384 |
| 86 | Alcoholism_Homo sapiens_hsa05034 | 0.37524855 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36577843 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36302341 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36158337 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35369502 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35069507 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.34211179 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34127307 |
| 94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.33565003 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33333892 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.33174619 |
| 97 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32253577 |
| 98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.31949490 |
| 99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31881278 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31245662 |
| 101 | Focal adhesion_Homo sapiens_hsa04510 | 0.30324303 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30285486 |
| 103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29835347 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29241247 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28498419 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28448692 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27946989 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27882116 |
| 109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27830057 |
| 110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27543029 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27287457 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26318828 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25620761 |
| 114 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.22017086 |

